一般社団法人日本呼吸器学会 公式サイト
日本呼吸器学会英文誌 Respiratory Investigation
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集

Abstract

Full Text of PDF Full Text of PDF (637k)
Article in Japanese

Topics Series Pulmonary circulation and lung injury

The new treatment strategy for pulmonary arterial hypertension

Yuichi Tamuraa,b  Keiichi Fukudaa 

aDepartment of Cardiology, Keio University School of Medicine
bCentre National de Référence de l'Hypertension Pulmonaire Sévère, Université de Paris

ABSTRACT

Because of specific treatment options, such as epoprostenol infusion therapy, the prognosis of pulmonary arterial hypertension (PAH) has dramatically improved. Compared with prognoses reported from Western countries, those in Japanese centers for PAH are better because Japanese specialists perform advanced therapies and make treatment goals that are not exercise tolerance, but pulmonary artery pressure. The research from multi-Japanese PAH centers revealed that patients achieving mean pulmonary artery pressure of less than 44.5 mmHg had good prognosis. This result suggests that advanced multiple drug treatment containing epoprostenol without hesitation improves prognosis.

KEYWORDS

Epoprostenol  Pulmonary artery pressure  Exercise tolerance  Treatment goal 

AJRS, 3(4): 486-491, 2014

Google Scholar